JNJ is pruning its portfolio while Abbott just dropped $21 billion to expand into cancer diagnostics, and the two strategies are pulling their stocks in completely opposite directions. Which move looks smarter when you…
Wall Street sees SpaceX doubling from here while one prominent analyst calls it worth half the current price, and the gap between those two targets is wider than almost any large-cap stock on the…
Wall Street keeps punishing Broadcom while its cash registers keep ringing, and one investor believes the gap between those two facts is the trade of the decade.
A Bicentennial quarter sold for over $19,000 at auction, and somewhere in America someone probably has one sitting in a junk drawer. One glance at a single spot on the coin tells you whether…
AMD's two-day AI summit could jolt a sector that investors are losing their nerve on, but the real story has nothing to do with the chips everyone already knows are coming.
A Senate deadline this Thursday could determine whether XRP gets the permanent legal protection institutional investors have been waiting on, or watches its biggest legislative catalyst quietly disappear until the next decade.
Credo Technology's revenue tripled and its stock soared over 1,600% in five years, yet shares just cratered 21% in a single week. Here is what that sell-off reveals about whether a $350 price target…
The federal government has been mailing checks to dead people for years, and Treasury Secretary Scott Bessent says a new verification system just caught the first wave. The numbers already stopped are notable, but…
Netflix has shed nearly half its value while the broader market climbed, yet dozens of Wall Street analysts refuse to cut bait and at least one major ratings house sees a share price that…
Howard Marks just filed five equity positions that look nothing like a bull-market portfolio, and every one has moved sharply since he bought. The question now is whether his thesis still holds at today's…
Tesla sits dead last among the Magnificent 7 in 2026, weighed down by inventory creep, collapsing energy revenue, and a valuation that makes even bulls sweat. But Q2 earnings could rewrite the narrative entirely,…
Hock Tan turned a struggling chip company into a trillion-dollar AI powerhouse through relentless acquisitions and brutal capital discipline. What that journey actually returned to patient investors since day one will make you rethink…
Most workers treat an HSA as a use-it-or-lose-it medical fund, but the account quietly transforms at 65 into something far more powerful, and the tax structure behind that shift is unlike anything else in…
Some dividend streaks survive a rough quarter, but a rare few have held through five decades of recessions, rate spikes, and oil crashes without missing a single raise. These five names show what that…
A research firm just ran the numbers on one of OpenAI's boldest revenue promises, and the gap between what OpenAI is projecting and what independent analysts see coming raises serious questions about the financial…
